AR064214A1 - Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas - Google Patents
Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadasInfo
- Publication number
- AR064214A1 AR064214A1 ARP070105516A ARP070105516A AR064214A1 AR 064214 A1 AR064214 A1 AR 064214A1 AR P070105516 A ARP070105516 A AR P070105516A AR P070105516 A ARP070105516 A AR P070105516A AR 064214 A1 AR064214 A1 AR 064214A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- osteoporosis
- epotilones
- related diseases
- osteoclastic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de epotilonas naturales o sintéticas para el tratamiento, la prevencion o la mitigacion de enfermedades causadas por el desequilibrio de la actividad osteoclástica y osteoblástica, especialmente la osteoporosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06025424A EP1930004A1 (en) | 2006-12-08 | 2006-12-08 | Use of epothilones in the treatment of osteoporosis and related diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064214A1 true AR064214A1 (es) | 2009-03-18 |
Family
ID=38008136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105516A AR064214A1 (es) | 2006-12-08 | 2007-12-10 | Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080146626A1 (es) |
EP (2) | EP1930004A1 (es) |
KR (1) | KR20090087038A (es) |
CN (1) | CN101553227A (es) |
AR (1) | AR064214A1 (es) |
AU (1) | AU2007327767A1 (es) |
BR (1) | BRPI0719997A2 (es) |
CA (1) | CA2672114A1 (es) |
CL (1) | CL2007003553A1 (es) |
IL (1) | IL198493A0 (es) |
MX (1) | MX2009006074A (es) |
TW (1) | TW200829239A (es) |
UY (1) | UY30769A1 (es) |
WO (1) | WO2008068043A1 (es) |
ZA (1) | ZA200904755B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA035193B1 (ru) | 2010-05-18 | 2020-05-14 | Серулин Фарма Инк. | Композиции и способы лечения аутоиммунных и других заболеваний |
RU2496511C1 (ru) * | 2012-04-20 | 2013-10-27 | Замертон Холдингс Лимитед | Фармацевтическая композиция, средство (варианты) и способ профилактики и лечения артрита, остеоартроза и остеохондроза позвоночника (варианты) |
MX2018004696A (es) * | 2015-10-16 | 2018-11-29 | Univ Rice William M | Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos. |
CN110974824A (zh) * | 2019-12-18 | 2020-04-10 | 中国人民解放军陆军军医大学第一附属医院 | 埃博霉素b在制备防治炎症性骨丢失药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6320045B1 (en) * | 1997-12-04 | 2001-11-20 | Bristol-Myers Squibb Company | Process for the reduction of oxiranyl epothilones to olefinic epothilones |
US6893859B2 (en) * | 2001-02-13 | 2005-05-17 | Kosan Biosciences, Inc. | Epothilone derivatives and methods for making and using the same |
AU2002338336A1 (en) * | 2001-04-03 | 2002-10-21 | Kosan Biosciences, Inc. | Epothilone derivatives and methods for making and using the same |
US20060069136A1 (en) * | 2004-09-24 | 2006-03-30 | Ulrich Klar | Use of Epothilones in the treatment of bone metastasis |
EP1640004A1 (en) * | 2004-09-24 | 2006-03-29 | Schering Aktiengesellschaft | Use of epothilones in the treatment of bone metastases and bone tumors or cancers |
-
2006
- 2006-12-08 EP EP06025424A patent/EP1930004A1/en not_active Withdrawn
-
2007
- 2007-12-05 CN CNA200780045413XA patent/CN101553227A/zh active Pending
- 2007-12-05 AU AU2007327767A patent/AU2007327767A1/en not_active Abandoned
- 2007-12-05 WO PCT/EP2007/010789 patent/WO2008068043A1/en active Application Filing
- 2007-12-05 BR BRPI0719997-0A2A patent/BRPI0719997A2/pt not_active Application Discontinuation
- 2007-12-05 EP EP07856543A patent/EP2101765A1/en not_active Withdrawn
- 2007-12-05 KR KR1020097011604A patent/KR20090087038A/ko not_active Application Discontinuation
- 2007-12-05 CA CA002672114A patent/CA2672114A1/en not_active Abandoned
- 2007-12-05 MX MX2009006074A patent/MX2009006074A/es not_active Application Discontinuation
- 2007-12-07 UY UY30769A patent/UY30769A1/es not_active Application Discontinuation
- 2007-12-07 CL CL200703553A patent/CL2007003553A1/es unknown
- 2007-12-07 TW TW096146830A patent/TW200829239A/zh unknown
- 2007-12-10 AR ARP070105516A patent/AR064214A1/es unknown
-
2008
- 2008-02-27 US US11/952,666 patent/US20080146626A1/en not_active Abandoned
-
2009
- 2009-04-30 IL IL198493A patent/IL198493A0/en unknown
- 2009-07-07 ZA ZA200904755A patent/ZA200904755B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20080146626A1 (en) | 2008-06-19 |
WO2008068043A1 (en) | 2008-06-12 |
EP1930004A1 (en) | 2008-06-11 |
ZA200904755B (en) | 2010-09-29 |
MX2009006074A (es) | 2009-08-24 |
EP2101765A1 (en) | 2009-09-23 |
KR20090087038A (ko) | 2009-08-14 |
CN101553227A (zh) | 2009-10-07 |
AU2007327767A1 (en) | 2008-06-12 |
TW200829239A (en) | 2008-07-16 |
CA2672114A1 (en) | 2008-06-12 |
BRPI0719997A2 (pt) | 2014-03-18 |
CL2007003553A1 (es) | 2008-07-04 |
IL198493A0 (en) | 2010-02-17 |
UY30769A1 (es) | 2008-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200800250A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
SV2009003299A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa | |
PA8770101A1 (es) | Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso | |
CL2009001099A1 (es) | Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune. | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
EA201200550A1 (ru) | Фармацевтические композиции, включающие bi-1356 и метформин | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
CL2007003520A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer. | |
ECSP088763A (es) | Nuevas combinaciones terapéuticas para el tratamiento de la depresión | |
CL2012002887A1 (es) | Combinación farmacéutica que comprende compuestos derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida, compuestos derivados de n-(2-arilamino)arilsulfonamida y opcionalmente otros agentes farmacéuticos adicionales; kit faramacéutico; método de tratamiento; y su uso para el tratamiento o la profilaxis del cáncer. | |
CL2007002920A1 (es) | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. | |
CL2007002380A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica. | |
ECSP088745A (es) | Derivados sustituidos de cromanol y su uso | |
CL2007003480A1 (es) | Compuestos derivados de tiazolo[5,4-c]piridin-4-ona sustituida; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento o prevencion de enfermedades relacionadas con la obesidad, como trastornos de la alimentacion, diab | |
AR058173A1 (es) | Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas | |
UY31133A1 (es) | "oxazolidinonas sustituidas y su uso" | |
CL2007003643A1 (es) | Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas. | |
CL2007003672A1 (es) | Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad. | |
UY29417A1 (es) | Agentes endoparasiticidas | |
CL2008002082A1 (es) | Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades. | |
UY29189A1 (es) | Nonadepsipeptidos acilados ii | |
PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso | |
CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |